Labiotech.eu

News and Trends 19 Oct 2016

The ‘First and Only’ Metastatic Lung Cancer Immunotherapy is approved

Roche’s Genentech has received FDA approval for an immunotherapy targeting the highly sought-after PD-L1. The treatment may be able to outperform its competitors in lung cancer therapies. In May, Roche received approval for Tecentriq (atezolizumab) in bladder cancer. Now, the drug is expanding its indications to become the first and only cancer immunotherapy in the market to target […]

October 19, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 19 Oct 2016

And the highest funding in Europe this year goes to… Antibody-Drug Conjugates!

AstraZeneca has contributed to ADC Therapeutics’ €96M fundraising, the biggest round so far in Europe this year. Will this huge investment pay out for the British-Swedish Big Pharma? ADC Therapeutics (ADCT) is a Swiss Biotech that develops antibody-drug conjugates (ADCs) for oncology applications. Its founder Auven Therapeutics and its partner AstraZeneca have participated in the biggest […]

October 19, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 19 Oct 2016

This Technology Opens new Horizons for Protein Production

Based in Cologne, Germany, Cevec focuses on human cell-based expression system for production of biological therapies. We’ve already covered their breakthroughs for safer gene therapy and the potential of CAP-GT for expression of viral vectors. Besides CAP-GT, CEVEC has also developed a cell line that can produce complex glycosylated proteins. A good example of glycosylated protein is […]

October 19, 2016 - 5 minutesmins - By Denise Neves Gameiro

News and Trends 18 Oct 2016

Shire’s leading Pancreatic Cancer drug is Back with a Bang

Pancreatic cancer is one of the nastiest kinds and most difficult to treat; the EMA has granted marketing authorization to Onivyde in the fight against it. Pancreatic cancer is the fourth-leading cause of death in Europe, and it represents a dramatically underserved need. Metastatic adenocarcinoma is almost always fatal, as it cannot be removed surgically […]

October 18, 2016 - 2 minutesmins - By Evelyn Warner

Screenshot 2016 10 18 at 5.42.27 PM e1476805403921

News and Trends 18 Oct 2016

This New Biotech wants to Regrow Neurons to cure Parkinson’s

Mavalon Therapeutics will develop a drug candidate for Parkinson’s that can stop the disease progression by activating the growth of dying neurons. Mavalon Therapeutics, born today in the UK, will be entirely dedicated to the development of a drug candidate to stop the progression of Parkinson’s. Domain Therapeutics has created this new company with a €9M investment […]

October 18, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Oct 2016

€4M Grant for a Cancer Vaccine that could Bench its Competitors

Hookipa just secured a huge grant from the Austrian government. The plan is to develop the strongest HPV vaccine ever and claim its place in the €2B head and neck cancer market. Hookipa, one of the hottest Biotechs in Vienna, develops vaccines based on a new class of viral vectors. Its platform has impressed the public sector and secured €4.16M from the Austrian […]

October 18, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Oct 2016

How can Cultured Meat solve World Hunger and Global Warming?

What is ‘cultured meat’ and how can it address the most pressing global problems? Let us introduce you to some of the brilliant minds behind it. The world’s population is predicted to reach almost 10 billion by 2050, and we don’t have the resources to feed all of them… yet. The meat industry currently uses 70% of […]

October 18, 2016 - 6 minutesmins - By Clara Rodríguez Fernández

signing contract PORTRAIT IMAGES ASIA BY NONWARIT fi

News and Trends 17 Oct 2016

TxCell lines up another duck in its CAR-Treg campaign

Novartis veteran Li Zhou has joined TxCell as the VP of cell engineering to oversee CAR-Treg programs for autoimmune and inflammation diseases. The French Treg maverick, TxCell, has hoovered up more talent to pioneer its hybrid CAR-Treg therapies: Li Zhou will be the new Vice President of the company’s cell engineering division. What we are doing here with CAR-Tregs to treat […]

October 17, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 17 Oct 2016

Meet the First Biotech to Jump on Autophagy After This Years’ Nobel Prize

Just after the Nobel Prize was awarded to the study of autophagy, PhoreMost announces a collaboration to target the process in neurodegenerative diseases. PhoreMost is a drug discovery company that focuses on finding ‘undruggable’ targets, such as the KRAS cancer gene. Now, the company has announced a collaboration with the University of Cambridge to start working […]

October 17, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Oct 2016

It’s not over yet for Opdivo; AbbVie takes a stand in Leukemia

The Committee on Medicinal Products for Human Use (CHMP) has handed down a pair of positive opinions of Opdivo and AbbVie’s leukemia therapy in their quests for EMA approval. Before the European Commission reviews an application for market authorization, it crosses the collective desk of the Committee on Medicinal Products for Human Use (CHMP). If […]

October 17, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 15 Oct 2016

This Scientist crystallises Bacteria for Stained Glass and Lace!

Simon Park is a scientist who wants to teach us about the microbiome through his art. Among his works are a self-portrait, lace and stained glass, all of which have been produced from bacteria! At Cafe Science, Dr. Simon Park, Senior Lecturer in Microbial Sciences at the University of Surrey, described the diversity and ubiquity […]

October 15, 2016 - 3 minutesmins - By Evelyn Warner

News and Trends 14 Oct 2016

This Biotech makes DNA Vaccines and Gene Therapy Possible in Lapland

After Grenoble, we fly north to Finland to meet Santa’s reindeer and earn his good graces before Christmas. After a trip to the sauna and down time with Angry Birds, whose creator hails from the country, we moseyed over to visit FIT Biotech, our biotech of the week. City: Tampere, Finland Founded: 1995 Employees: 12 + […]

October 14, 2016 - 2 minutesmins - By Evelyn Warner

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The ‘First and Only’ Metastatic Lung Cancer Immunotherapy is approved

And the highest funding in Europe this year goes to… Antibody-Drug Conjugates!

This Technology Opens new Horizons for Protein Production

Shire’s leading Pancreatic Cancer drug is Back with a Bang

This New Biotech wants to Regrow Neurons to cure Parkinson’s

€4M Grant for a Cancer Vaccine that could Bench its Competitors

How can Cultured Meat solve World Hunger and Global Warming?

TxCell lines up another duck in its CAR-Treg campaign

Meet the First Biotech to Jump on Autophagy After This Years’ Nobel Prize

It’s not over yet for Opdivo; AbbVie takes a stand in Leukemia

This Scientist crystallises Bacteria for Stained Glass and Lace!

This Biotech makes DNA Vaccines and Gene Therapy Possible in Lapland

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!